ITMCTR2000003313招募中1 期
Randomized double-blind parallel controlled clinical trail of Chenpi enzyme in the treatment of hyperlipidemia
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 性别
- All
入选标准
- •1. Patients aged 18-75 years;
- •2. Patients with dyslipidemia;
- •3. The cardiovascular risk was assessed as low risk patients;
- •4. Those who voluntarily participate in the research and sign the informed consent.
排除标准
- •1. Patients who were taking antilipidemic drugs within 3 months before inclusion;
- •2. Patients with nephrotic syndrome, hypothyroidism, renal failure, liver disease and systemic lupus erythematosus;
- •3. Patients with myeloma, glycogen accumulation, fatty atrophy, acute porphyria and polycystic ovary syndrome;
- •4. Patients taking drugs related to lipid metabolism, such as diuretics, beta blockers, glucocorticoids, metformin, insulin and contraceptives;
- •5. Patients whose systolic blood pressure is still >= 180mmhg or diastolic blood pressure is still >= 110mhg after treatment;
- •6. After oral drug treatment, the blood glucose is still >= 11.1mmol/L Of patients;
- •7. TG >= 5.65mmol/L Those who;
- •8. Patients with heart, liver, kidney, hematopoietic system, immune system and other systemic serious diseases;
- •9. Pregnant or lactating women or those who plan to be pregnant during the trial period or their spouses plan to be pregnant;
- •10. Patients with allergic constitution, possible allergy to the drug or psychosis;
- •11. Other patients who cannot cooperate for a long time.
研究者
相似试验
尚未招募
1 期
Randomized double-blind parallel controlled clinical study of tangerine peel enzyme in the treatment of chronic functional constipatioITMCTR2000003314Guangdong Provinc Traditional Chinese Medical Hospital
已完成
1 期
A randomized, double-blind, parallel controlled clinical study of tangerine peel enzyme in the treatment of insomnia with deficiency of heart and spleeinsomniaITMCTR2200005639Guangdong Hospital of traditional Chinese Medicine
招募中
Unknown
A Randomized, Double-Blind, Parallel Group Clinical Study To Evaluate Efficacy And Safety Of UO ABG 01 In The Management Of Borderline Cardio Vascular Risk FactorsCTRI/2023/10/058501Xtractiva Life Science Private Limited
进行中（未招募）
1 期
A randomized, double-blind, parallel group clinical trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of intravenous mepolizumab (SB240563) (0.55mg/kg, 2.5mg/kg or 10mg/kg) in pediatric subjects with eosinophilic esophagitis, aged 2 to 17 years - Mepolizumab in paediatric eosinophilic oesophagitisEosinophilic oesophagitisEUCTR2005-006074-10-GBGlaxoSmithKline Research & Development Ltd.72
招募中
3 期
Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant AlbendazoleOnchocerciasisPACTR202003567524647Medicines Development for Global Health12,500